These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8948508)

  • 21. Constrictor responses to noradrenaline, hemodynamic profile, and superoxide levels measured by hydroethidine oxidation in diabetic rats.
    Sartoretto JL; Oliveira MA; Nigro D; Carvalho MH; Tostes RC; Fortes ZB
    Biol Pharm Bull; 2007 Oct; 30(10):1938-42. PubMed ID: 17917266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats.
    Miric G; Dallemagne C; Endre Z; Margolin S; Taylor SM; Brown L
    Br J Pharmacol; 2001 Jul; 133(5):687-94. PubMed ID: 11429393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of nitric oxide- and prostaglandin-independent vasodilation of retinal arterioles induced by acetylcholine in streptozotocin-treated rats.
    Nakazawa T; Kaneko Y; Mori A; Saito M; Sakamoto K; Nakahara T; Ishii K
    Vascul Pharmacol; 2007 Mar; 46(3):153-9. PubMed ID: 17079193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ruthenium-based nitric oxide scavenger, AMD6221, augments cardiovascular responsiveness to noradrenaline in rats with streptozotocin-induced diabetes.
    Hutchings SR; Song D; Fricker SP; Pang CC
    Eur J Pharmacol; 2005 Dec; 528(1-3):132-6. PubMed ID: 16310182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of insulin treatment on changes in vascular reactivity in chronic, experimental diabetes.
    MacLeod KM
    Diabetes; 1985 Nov; 34(11):1160-7. PubMed ID: 3899813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular sensitivity and reactivity to norepinephrine in diabetes mellitus.
    Friedman JJ
    Am J Physiol; 1989 Apr; 256(4 Pt 2):H1134-8. PubMed ID: 2705555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low molecular weight fucoidan ameliorates streptozotocin-induced hyper-responsiveness of aortic smooth muscles in type 1 diabetes rats.
    Liang Z; Zheng Y; Wang J; Zhang Q; Ren S; Liu T; Wang Z; Luo D
    J Ethnopharmacol; 2016 Sep; 191():341-349. PubMed ID: 27346541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered arachidonic acid-mediated responses in the perfused kidney of the streptozotocin-induced diabetic rat.
    Kamata K; Hosokawa M; Matsumoto T; Kobayashi T
    J Smooth Muscle Res; 2006 Oct; 42(5):171-87. PubMed ID: 17159333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of exposure to cigarette smoke on microvascular reactivity to noradrenaline in cremaster muscles in rats.
    Chen SH; Lee YH; Lee YH; Lee J; Wei FC; Chen HC
    Scand J Plast Reconstr Surg Hand Surg; 2002; 36(3):129-34. PubMed ID: 12141199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes.
    Chao PC; Li Y; Chang CH; Shieh JP; Cheng JT; Cheng KC
    Biomed Pharmacother; 2018 May; 101():155-161. PubMed ID: 29486333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contractile responses to various stimuli in isolated resistance vessels from simultaneously hypertensive and streptozotocin-diabetic rats.
    Kam KL; Hendriks MG; Pijl AJ; van Marle J; van Veen HA; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):167-75. PubMed ID: 8656652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal arteriolar contractile responses to angiotensin II in rats with poorly controlled diabetes mellitus.
    Carmines PK; Ohishi K
    Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):877-82. PubMed ID: 10561808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prostanoids on phenylephrine-induced contractions in the mesenteric vascular bed of rats with streptozotocin-induced diabetes mellitus.
    Carvalho Leone AF; Coelho EB
    Life Sci; 2004 Dec; 76(3):239-47. PubMed ID: 15531377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
    Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C;
    J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Hoe-140 and ramiprilat on arteriolar tone and dilation to bradykinin in skeletal muscle of rats.
    Koller A; Rodenburg JM; Kaley G
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1628-33. PubMed ID: 7733364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of myogenic enhancement by norepinephrine.
    Liu J; Hill MA; Meininger GA
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H440-6. PubMed ID: 7511346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide opposes myogenic pressure responses predominantly in large arterioles in vivo.
    de Wit C; Jahrbeck B; Schäfer C; Bolz SS; Pohl U
    Hypertension; 1998 Mar; 31(3):787-94. PubMed ID: 9495262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed.
    Benter IF; Yousif MH; Griffiths SM; Benboubetra M; Akhtar S
    Br J Pharmacol; 2005 Jul; 145(6):829-36. PubMed ID: 15852031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists.
    Inscho EW; Carmines PK; Navar LG
    Am J Physiol; 1990 Jul; 259(1 Pt 2):F157-63. PubMed ID: 2115739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral endothelial dysfunction in diabetes: intravital microscopic analysis using streptozotocin-induced diabetic rats.
    Jariyapongskul A; Patumraj S; Niimi H
    Clin Hemorheol Microcirc; 2003; 29(3-4):331-5. PubMed ID: 14724358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.